Latest return on equity
Contineum Therapeutics Return on equity
Contineum Therapeutics (CTNM) return on equity with its verified observation da…
Direct answer
Contineum Therapeutics's return on equity is -28%.
The verified market snapshot reports -28%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 29, 2026.
Get free Contineum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -28%
Explore related company data
View Contineum Therapeutics's market capitalizationView Contineum Therapeutics's price-to-book ratioView Contineum Therapeutics's 52-week price rangeView Contineum Therapeutics's profit marginView Contineum Therapeutics's debt-to-equity ratioView all Contineum Therapeutics key metricsReturn to Contineum Therapeutics profile